161 related articles for article (PubMed ID: 31926049)
1. Cardiofaciocutaneous syndrome with KRAS gene mutation presenting as chylopericardium.
Akahoshi S; Hirano A; Nagamine H; Miura M
Am J Med Genet A; 2020 Mar; 182(3):532-535. PubMed ID: 31926049
[TBL] [Abstract][Full Text] [Related]
2. Unusual hair findings in a child with cardiofaciocutaneous syndrome.
Işikay S; Karaer K
Int J Dermatol; 2019 Mar; 58(3):354-356. PubMed ID: 30094826
[No Abstract] [Full Text] [Related]
3. LYMPHODYSPLASIA AND KRAS MUTATION: A CASE REPORT AND LITERATURE REVIEW.
Morcaldi G; Bellini T; Rossi C; Maghnie M; Boccardo F; Bonioli E; Bellini C
Lymphology; 2015 Sep; 48(3):121-7. PubMed ID: 26939159
[TBL] [Abstract][Full Text] [Related]
4. [Cardiofaciocutaneous syndrome, a Noonan syndrome related disorder: clinical and molecular findings in 11 patients].
Carcavilla A; García-Miñaúr S; Pérez-Aytés A; Vendrell T; Pinto I; Guillén-Navarro E; González-Meneses A; Aoki Y; Grinberg D; Ezquieta B
Med Clin (Barc); 2015 Jan; 144(2):67-72. PubMed ID: 25194980
[TBL] [Abstract][Full Text] [Related]
5. Fetal autopsy findings of cardiofaciocutaneous syndrome with a unique BRAF mutation.
Terry J; Rauen KA; Nowaczyk MJ
Pediatr Dev Pathol; 2014; 17(1):59-63. PubMed ID: 24303953
[TBL] [Abstract][Full Text] [Related]
6. A sibling pair with cardiofaciocutaneous syndrome (CFC) secondary to BRAF mutation with unaffected parents-the first cases of gonadal mosaicism in CFC?
Geoghegan S; King G; Henchliffe J; Ramsden SC; Barry RJ; Green AJ; O'Connell SM
Am J Med Genet A; 2018 Jul; 176(7):1637-1640. PubMed ID: 29704308
[TBL] [Abstract][Full Text] [Related]
7. Cardiofaciocutaneous syndrome and the dermatologist's contribution to diagnosis.
Rocha VB; Moraes RA; Pereira LB
Cutis; 2017 Jan; 99(1):E4-E7. PubMed ID: 28207016
[No Abstract] [Full Text] [Related]
8. Clinical and molecular characterization of children with Noonan syndrome and other RASopathies in Argentina.
Chinton J; Huckstadt V; Moresco A; Gravina LP; Obregon MG
Arch Argent Pediatr; 2019 Oct; 117(5):330-337. PubMed ID: 31560489
[TBL] [Abstract][Full Text] [Related]
9. Clinical Report: Cognitive decline in a patient with Cardiofaciocutaneous syndrome.
Cabrera S; Morel C; Tartaglia MC
Am J Med Genet A; 2016 May; 170A(5):1251-6. PubMed ID: 26842671
[TBL] [Abstract][Full Text] [Related]
10. Clinical and molecular analysis of RASopathies in a group of Turkish patients.
Şimşek-Kiper PÖ; Alanay Y; Gülhan B; Lissewski C; Türkyilmaz D; Alehan D; Cetin M; Utine GE; Zenker M; Boduroğlu K
Clin Genet; 2013 Feb; 83(2):181-6. PubMed ID: 22420426
[TBL] [Abstract][Full Text] [Related]
11. Familial cardiofaciocutaneous syndrome in a father and a son with a novel MEK2 mutation.
Karaer K; Lissewski C; Zenker M
Am J Med Genet A; 2015 Feb; 167A(2):385-8. PubMed ID: 25487361
[TBL] [Abstract][Full Text] [Related]
12. An adult case of cardiofaciocutaneous syndrome with BRAF mutation.
Sato S; Hida T; Okura M; Ishikawa A; Yamashita T
Eur J Dermatol; 2017 Aug; 27(4):412-413. PubMed ID: 28524057
[No Abstract] [Full Text] [Related]
13. Familial cardio-facio-cutaneous syndrome: Vertical transmission of the BRAF p.G464R pathogenic variant and review of the literature.
Rauen KA; Maeda Y; Egense A; Tidyman WE
Am J Med Genet A; 2021 Feb; 185(2):469-475. PubMed ID: 33274568
[TBL] [Abstract][Full Text] [Related]
14. Antenatal diagnosis of cardio-facio-cutaneous syndrome: Prenatal characteristics and contribution of fetal facial dysmorphic signs in utero. About a case and review of literature.
Biard JM; Steenhaut P; Bernard P; Race V; Sznajer Y
Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():232-241. PubMed ID: 31336229
[TBL] [Abstract][Full Text] [Related]
15. Dermatological findings in 61 mutation-positive individuals with cardiofaciocutaneous syndrome.
Siegel DH; McKenzie J; Frieden IJ; Rauen KA
Br J Dermatol; 2011 Mar; 164(3):521-9. PubMed ID: 21062266
[TBL] [Abstract][Full Text] [Related]
16. Genotype and phenotype spectrum of NRAS germline variants.
Altmüller F; Lissewski C; Bertola D; Flex E; Stark Z; Spranger S; Baynam G; Buscarilli M; Dyack S; Gillis J; Yntema HG; Pantaleoni F; van Loon RL; MacKay S; Mina K; Schanze I; Tan TY; Walsh M; White SM; Niewisch MR; García-Miñaúr S; Plaza D; Ahmadian MR; Cavé H; Tartaglia M; Zenker M
Eur J Hum Genet; 2017 Jun; 25(7):823-831. PubMed ID: 28594414
[TBL] [Abstract][Full Text] [Related]
17. [Mutagenic effect of advanced paternal age in neurocardiofaciocutaneous syndrome].
Seemanová E; Zenker M
Cas Lek Cesk; 2014; 153(5):242-5. PubMed ID: 25370770
[TBL] [Abstract][Full Text] [Related]
18. Perinatal features of the RASopathies: Noonan syndrome, cardiofaciocutaneous syndrome and Costello syndrome.
Myers A; Bernstein JA; Brennan ML; Curry C; Esplin ED; Fisher J; Homeyer M; Manning MA; Muller EA; Niemi AK; Seaver LH; Hintz SR; Hudgins L
Am J Med Genet A; 2014 Nov; 164A(11):2814-21. PubMed ID: 25250515
[TBL] [Abstract][Full Text] [Related]
19. Immunoglobulin deficiency associated with a MAP2K1-related mutation causing cardio-facio-cutaneous syndrome.
Leoni C; Tedesco M; Onesimo R; Giorgio V; Rigante D; Zampino G
Immunol Lett; 2020 Nov; 227():79-80. PubMed ID: 32866538
[No Abstract] [Full Text] [Related]
20. Clinicopathologic evaluation of cardiofaciocutaneous syndrome: overcoming the challenges of diagnosing a rare genodermatosis.
Bryan ZT; Missall TA; Stieren S; Siegfried E; Burkemper NM
Pediatr Dermatol; 2015; 32(1):e23-8. PubMed ID: 25514835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
